Sign in

CIK 0001869105 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

BridgeBio Oncology Therapeutics, Inc.

Sign in to watch
Ticker
BBOT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857 702 0377
Business address
256 E. GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO, CA, 94080
Former names
Helix Acquisition Corp. II
  1. SC 13G Stake Amended Statement of Ownership
  2. 8-K Event Material agreement · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Other events
  3. 4 Open-market buy CEO and Chairperson bought 2,400,000 shares at $10.00 ($24,000,000)
  4. 4 Grant or award Director acquired 509,000 shares (grant or award)
  5. 424B4 Offering Prospectus
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. EFFECT Other Notice of Effectiveness
  10. S-1MEF Other S-1MEF
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. CERT Other Certification
  15. 8-A12B Other Registration of Securities
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. S-1/A Offering Registration Statement
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. UPLOAD Other SEC-generated Letter

Page 9 of 10 · 187 filings